Mukadder Ozcan

Mukadder Ozcan serves as Assistant Professor of Anesthesiology at Yale School of Medicine, where she joined in 2020. She is a core member of the Division of Adult Multispecialty Anesthesia and holds affiliate status with Yale Cancer Center's Cancer Prevention and Control Program. Her clinical expertise centers on providing comprehensive perioperative care for surgical oncology patients, specializing in gynecological, urologic, and general cancer procedures.

Dr. Ozcan's academic journey includes:

• MD from Dicle University School of Medicine, Diyarbakir, Turkey (1992)
• Anesthesiology Residency at Istanbul University Cerrahpasa School of Medicine
• US Residency at University of Oklahoma Department of Anesthesiology (2016)
• Board Certification by American Board of Anesthesiologists (2017)

Her research interests bridge clinical anesthesiology and cancer care, focusing on perioperative optimization for oncology patients and prevention strategies within surgical settings. As an affiliate of Yale's Cancer Prevention and Control Program, she contributes to initiatives addressing anesthesia-related factors in cancer outcomes and survivorship. Her work emphasizes evidence-based approaches to managing complex surgical cases while minimizing stress responses that could impact cancer progression.

Dr. Ozcan maintains active roles in residency education and institutional governance, serving on Yale's Faculty Advisory Council and Departmental Faculty Engagement Committee. She mentors anesthesiology residents in oncology rotations and advocates for faculty development within academic medicine. Her clinical team collaborates closely with surgical oncologists, medical oncologists, and perioperative support services to deliver integrated cancer care.

While not leading a formal research laboratory, Dr. Ozcan participates in Yale Cancer Center's multidisciplinary research ecosystem through her Cancer Prevention and Control Program affiliation. Her clinical practice provides foundational data for quality improvement initiatives in oncological anesthesia, with potential translational applications in cancer surgery outcomes research.